Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and the effectiveness of two doses of metoclopramide nasal spray
solution, 10 mg and 14 mg, compared to placebo in reducing the symptoms of diabetic
gastroparesis.